In ovarian stromal cells of PCOS patients, LH enhances CYP17A1 phosphorylation via the cAMP/PKA pathway, upregulating 17-hydroxylase and 17,20-lyase activities and leading to excessive production of androstenedione and testosterone (58)
Xu XQ, Jing ZC, Jiang X, et al
For these effects, the drug was first approved by the FDA for the management of T2D in adults in 2010, then, in 2014, for the treatment of obesity in adults who have at least one weight-related condition, and later on, in 2019, also for the treatment of children 10 years or older with T2D
Sequoia data finds that GLP-1 medications average around $1,000 per prescription, posing financial challenges for employers who provide health benefits
In RAW 264.7 macrophages, GHK-Cu significantly mitigated the LPS-induced increase in ROS production